- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
According to our latest study, the global Antibody market size was valued at USD 9354.2 million in 2022 and is forecast to a readjusted size of USD 13230 million by 2029 with a CAGR of 5.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
This report is a detailed and comprehensive analysis for global Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antibody market size and forecasts, in consumption value ($ Million), sales quantity (KG), and average selling prices (USD/KG), 2018-2029
Global Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (KG), and average selling prices (USD/KG), 2018-2029
Global Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (KG), and average selling prices (USD/KG), 2018-2029
Global Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (KG), and ASP (USD/KG), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Johnson and Johnson, Merck, Novartis and AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
IgM
IgG
IgA
Other
Market segment by Application
Therapeutic
Research
Diagnostic
Major players covered
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antibody, with price, sales, revenue and global market share of Antibody from 2018 to 2023.
Chapter 3, the Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antibody.
Chapter 14 and 15, to describe Antibody sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 IgM
1.3.3 IgG
1.3.4 IgA
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Therapeutic
1.4.3 Research
1.4.4 Diagnostic
1.5 Global Antibody Market Size & Forecast
1.5.1 Global Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Antibody Sales Quantity (2018-2029)
1.5.3 Global Antibody Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Antibody Product and Services
2.1.4 Roche Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Johnson and Johnson
2.2.1 Johnson and Johnson Details
2.2.2 Johnson and Johnson Major Business
2.2.3 Johnson and Johnson Antibody Product and Services
2.2.4 Johnson and Johnson Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson and Johnson Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Antibody Product and Services
2.3.4 Merck Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Antibody Product and Services
2.4.4 Novartis Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business
2.5.3 AbbVie Antibody Product and Services
2.5.4 AbbVie Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AbbVie Recent Developments/Updates
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Antibody Product and Services
2.6.4 Amgen Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amgen Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Antibody Product and Services
2.7.4 Pfizer Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Antibody Product and Services
2.8.4 Bayer Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bayer Recent Developments/Updates
2.9 Lilly
2.9.1 Lilly Details
2.9.2 Lilly Major Business
2.9.3 Lilly Antibody Product and Services
2.9.4 Lilly Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lilly Recent Developments/Updates
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business
2.10.3 Bristol-Myers Squibb Antibody Product and Services
2.10.4 Bristol-Myers Squibb Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bristol-Myers Squibb Recent Developments/Updates
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Antibody Product and Services
2.11.4 GlaxoSmithKline Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 GlaxoSmithKline Recent Developments/Updates
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Antibody Product and Services
2.12.4 Biogen Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Biogen Recent Developments/Updates
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business
2.13.3 AstraZeneca Antibody Product and Services
2.13.4 AstraZeneca Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 AstraZeneca Recent Developments/Updates
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Antibody Product and Services
2.14.4 Sanofi Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sanofi Recent Developments/Updates
2.15 Alexion Pharmaceuticals
2.15.1 Alexion Pharmaceuticals Details
2.15.2 Alexion Pharmaceuticals Major Business
2.15.3 Alexion Pharmaceuticals Antibody Product and Services
2.15.4 Alexion Pharmaceuticals Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Alexion Pharmaceuticals Recent Developments/Updates
2.16 Seattle Genetics
2.16.1 Seattle Genetics Details
2.16.2 Seattle Genetics Major Business
2.16.3 Seattle Genetics Antibody Product and Services
2.16.4 Seattle Genetics Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Seattle Genetics Recent Developments/Updates
3 Competitive Environment: Antibody by Manufacturer
3.1 Global Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global Antibody Revenue by Manufacturer (2018-2023)
3.3 Global Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 Antibody Manufacturer Market Share in 2022
3.5 Antibody Market: Overall Company Footprint Analysis
3.5.1 Antibody Market: Region Footprint
3.5.2 Antibody Market: Company Product Type Footprint
3.5.3 Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Antibody Market Size by Region
4.1.1 Global Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global Antibody Consumption Value by Region (2018-2029)
4.1.3 Global Antibody Average Price by Region (2018-2029)
4.2 North America Antibody Consumption Value (2018-2029)
4.3 Europe Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific Antibody Consumption Value (2018-2029)
4.5 South America Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa Antibody Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Antibody Sales Quantity by Type (2018-2029)
5.2 Global Antibody Consumption Value by Type (2018-2029)
5.3 Global Antibody Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Antibody Sales Quantity by Application (2018-2029)
6.2 Global Antibody Consumption Value by Application (2018-2029)
6.3 Global Antibody Average Price by Application (2018-2029)
7 North America
7.1 North America Antibody Sales Quantity by Type (2018-2029)
7.2 North America Antibody Sales Quantity by Application (2018-2029)
7.3 North America Antibody Market Size by Country
7.3.1 North America Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Antibody Sales Quantity by Type (2018-2029)
8.2 Europe Antibody Sales Quantity by Application (2018-2029)
8.3 Europe Antibody Market Size by Country
8.3.1 Europe Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Antibody Market Size by Region
9.3.1 Asia-Pacific Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Antibody Sales Quantity by Type (2018-2029)
10.2 South America Antibody Sales Quantity by Application (2018-2029)
10.3 South America Antibody Market Size by Country
10.3.1 South America Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Antibody Market Size by Country
11.3.1 Middle East & Africa Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Antibody Market Drivers
12.2 Antibody Market Restraints
12.3 Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antibody
13.3 Antibody Production Process
13.4 Antibody Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antibody Typical Distributors
14.3 Antibody Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Antibody Product and Services
Table 6. Roche Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson and Johnson Major Business
Table 10. Johnson and Johnson Antibody Product and Services
Table 11. Johnson and Johnson Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Johnson and Johnson Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Antibody Product and Services
Table 16. Merck Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Antibody Product and Services
Table 21. Novartis Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. AbbVie Basic Information, Manufacturing Base and Competitors
Table 24. AbbVie Major Business
Table 25. AbbVie Antibody Product and Services
Table 26. AbbVie Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AbbVie Recent Developments/Updates
Table 28. Amgen Basic Information, Manufacturing Base and Competitors
Table 29. Amgen Major Business
Table 30. Amgen Antibody Product and Services
Table 31. Amgen Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Amgen Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Antibody Product and Services
Table 36. Pfizer Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Bayer Basic Information, Manufacturing Base and Competitors
Table 39. Bayer Major Business
Table 40. Bayer Antibody Product and Services
Table 41. Bayer Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bayer Recent Developments/Updates
Table 43. Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Lilly Major Business
Table 45. Lilly Antibody Product and Services
Table 46. Lilly Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Lilly Recent Developments/Updates
Table 48. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 49. Bristol-Myers Squibb Major Business
Table 50. Bristol-Myers Squibb Antibody Product and Services
Table 51. Bristol-Myers Squibb Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Bristol-Myers Squibb Recent Developments/Updates
Table 53. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 54. GlaxoSmithKline Major Business
Table 55. GlaxoSmithKline Antibody Product and Services
Table 56. GlaxoSmithKline Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. Biogen Basic Information, Manufacturing Base and Competitors
Table 59. Biogen Major Business
Table 60. Biogen Antibody Product and Services
Table 61. Biogen Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Biogen Recent Developments/Updates
Table 63. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 64. AstraZeneca Major Business
Table 65. AstraZeneca Antibody Product and Services
Table 66. AstraZeneca Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. AstraZeneca Recent Developments/Updates
Table 68. Sanofi Basic Information, Manufacturing Base and Competitors
Table 69. Sanofi Major Business
Table 70. Sanofi Antibody Product and Services
Table 71. Sanofi Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sanofi Recent Developments/Updates
Table 73. Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Alexion Pharmaceuticals Major Business
Table 75. Alexion Pharmaceuticals Antibody Product and Services
Table 76. Alexion Pharmaceuticals Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Alexion Pharmaceuticals Recent Developments/Updates
Table 78. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 79. Seattle Genetics Major Business
Table 80. Seattle Genetics Antibody Product and Services
Table 81. Seattle Genetics Antibody Sales Quantity (KG), Average Price (USD/KG), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Seattle Genetics Recent Developments/Updates
Table 83. Global Antibody Sales Quantity by Manufacturer (2018-2023) & (KG)
Table 84. Global Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Antibody Average Price by Manufacturer (2018-2023) & (USD/KG)
Table 86. Market Position of Manufacturers in Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Antibody Production Site of Key Manufacturer
Table 88. Antibody Market: Company Product Type Footprint
Table 89. Antibody Market: Company Product Application Footprint
Table 90. Antibody New Market Entrants and Barriers to Market Entry
Table 91. Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Antibody Sales Quantity by Region (2018-2023) & (KG)
Table 93. Global Antibody Sales Quantity by Region (2024-2029) & (KG)
Table 94. Global Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Antibody Average Price by Region (2018-2023) & (USD/KG)
Table 97. Global Antibody Average Price by Region (2024-2029) & (USD/KG)
Table 98. Global Antibody Sales Quantity by Type (2018-2023) & (KG)
Table 99. Global Antibody Sales Quantity by Type (2024-2029) & (KG)
Table 100. Global Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Antibody Average Price by Type (2018-2023) & (USD/KG)
Table 103. Global Antibody Average Price by Type (2024-2029) & (USD/KG)
Table 104. Global Antibody Sales Quantity by Application (2018-2023) & (KG)
Table 105. Global Antibody Sales Quantity by Application (2024-2029) & (KG)
Table 106. Global Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Antibody Average Price by Application (2018-2023) & (USD/KG)
Table 109. Global Antibody Average Price by Application (2024-2029) & (USD/KG)
Table 110. North America Antibody Sales Quantity by Type (2018-2023) & (KG)
Table 111. North America Antibody Sales Quantity by Type (2024-2029) & (KG)
Table 112. North America Antibody Sales Quantity by Application (2018-2023) & (KG)
Table 113. North America Antibody Sales Quantity by Application (2024-2029) & (KG)
Table 114. North America Antibody Sales Quantity by Country (2018-2023) & (KG)
Table 115. North America Antibody Sales Quantity by Country (2024-2029) & (KG)
Table 116. North America Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Antibody Sales Quantity by Type (2018-2023) & (KG)
Table 119. Europe Antibody Sales Quantity by Type (2024-2029) & (KG)
Table 120. Europe Antibody Sales Quantity by Application (2018-2023) & (KG)
Table 121. Europe Antibody Sales Quantity by Application (2024-2029) & (KG)
Table 122. Europe Antibody Sales Quantity by Country (2018-2023) & (KG)
Table 123. Europe Antibody Sales Quantity by Country (2024-2029) & (KG)
Table 124. Europe Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Antibody Sales Quantity by Type (2018-2023) & (KG)
Table 127. Asia-Pacific Antibody Sales Quantity by Type (2024-2029) & (KG)
Table 128. Asia-Pacific Antibody Sales Quantity by Application (2018-2023) & (KG)
Table 129. Asia-Pacific Antibody Sales Quantity by Application (2024-2029) & (KG)
Table 130. Asia-Pacific Antibody Sales Quantity by Region (2018-2023) & (KG)
Table 131. Asia-Pacific Antibody Sales Quantity by Region (2024-2029) & (KG)
Table 132. Asia-Pacific Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Antibody Sales Quantity by Type (2018-2023) & (KG)
Table 135. South America Antibody Sales Quantity by Type (2024-2029) & (KG)
Table 136. South America Antibody Sales Quantity by Application (2018-2023) & (KG)
Table 137. South America Antibody Sales Quantity by Application (2024-2029) & (KG)
Table 138. South America Antibody Sales Quantity by Country (2018-2023) & (KG)
Table 139. South America Antibody Sales Quantity by Country (2024-2029) & (KG)
Table 140. South America Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Antibody Sales Quantity by Type (2018-2023) & (KG)
Table 143. Middle East & Africa Antibody Sales Quantity by Type (2024-2029) & (KG)
Table 144. Middle East & Africa Antibody Sales Quantity by Application (2018-2023) & (KG)
Table 145. Middle East & Africa Antibody Sales Quantity by Application (2024-2029) & (KG)
Table 146. Middle East & Africa Antibody Sales Quantity by Region (2018-2023) & (KG)
Table 147. Middle East & Africa Antibody Sales Quantity by Region (2024-2029) & (KG)
Table 148. Middle East & Africa Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Antibody Raw Material
Table 151. Key Manufacturers of Antibody Raw Materials
Table 152. Antibody Typical Distributors
Table 153. Antibody Typical Customers
List of Figures
Figure 1. Antibody Picture
Figure 2. Global Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antibody Consumption Value Market Share by Type in 2022
Figure 4. IgM Examples
Figure 5. IgG Examples
Figure 6. IgA Examples
Figure 7. Other Examples
Figure 8. Global Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Antibody Consumption Value Market Share by Application in 2022
Figure 10. Therapeutic Examples
Figure 11. Research Examples
Figure 12. Diagnostic Examples
Figure 13. Global Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Antibody Sales Quantity (2018-2029) & (KG)
Figure 16. Global Antibody Average Price (2018-2029) & (USD/KG)
Figure 17. Global Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Antibody Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Antibody Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Antibody Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Antibody Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Antibody Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Antibody Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Antibody Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Antibody Average Price by Type (2018-2029) & (USD/KG)
Figure 32. Global Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Antibody Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Antibody Average Price by Application (2018-2029) & (USD/KG)
Figure 35. North America Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Antibody Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Antibody Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Antibody Consumption Value Market Share by Region (2018-2029)
Figure 55. China Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Antibody Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Antibody Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Antibody Market Drivers
Figure 76. Antibody Market Restraints
Figure 77. Antibody Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Antibody in 2022
Figure 80. Manufacturing Process Analysis of Antibody
Figure 81. Antibody Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
